news

« BACK

Pharmacology



Results 1 - 20 of 603.
1 2 3 4 5 ... 31 Next »


Health - Pharmacology - 20.01.2022
More than a third of care home residents caught Covid-19 in early waves of pandemic
More than a third of care home residents caught Covid-19 in early waves of pandemic
More than a third of care home residents and a quarter of care home staff in England showed evidence of infection with SARS-CoV-2 during the first two waves of the pandemic, according to a new study led by UCL researchers. The study, published in The Lancet Healthy Longevity , looked at blood samples from nearly 5,000 residents (with a median age of 87) and staff (with a median age of 48) at 201 care homes across England between June 2020 and May 2021.

Pharmacology - Health - 19.01.2022
New blood cancer gene defect can be treated with existing drugs
Share this page Share on Twitter Share on facebook Share on linkedin Share on email A defective gene normally found in blood cancers could be treated with drugs already available for cancers with similar gene defects, scientists at the University of Birmingham and Queen's University Belfast have revealed.

Health - Pharmacology - 18.01.2022
'Off target' effects of drugs used for autoimmune disorders needs better treatment strategy
’Off target’ effects of drugs used for autoimmune disorders needs better treatment strategy
New therapies for autoimmune rheumatic diseases (AIRDs) that are designed to better regulate lipid (fat) metabolism, could significantly reduce the harmful side-effects caused by conventional treatments, finds a new large-scale review led by UCL researchers. AIRDs affect millions globally and include rheumatoid arthritis, lupus and Sjögren's syndrome - all with high rates of morbidity.

Pharmacology - Life Sciences - 13.01.2022
Promising novel treatment for Dry Eye Disease revealed by new research
Promising novel treatment for Dry Eye Disease revealed by new research
The University of Manchester, Seoul National University College of Medicine and Link Biologics Limited today announced that promising preclinical data on the treatment of Dry Eye Disease using a novel protein biological drug, Link_TSG6, have been published in the peer-reviewed journal, Ocular Surface .

Physics - Pharmacology - 13.01.2022
Keeping up with the first law of robotics: A new photonic effect for accelerated drug discovery
Keeping up with the first law of robotics: A new photonic effect for accelerated drug discovery
Physicists at the University of Bath and University of Michigan demonstrate a new photonic effect in semiconducting nanohelices. A new photonic effect in semiconducting helical particles with nanoscale dimensions has been discovered by an international team of scientists led by researchers at the University of Bath.

Health - Pharmacology - 05.01.2022
New test can identify if a patient has cancer and if it has spread
New test can identify if a patient has cancer and if it has spread
A publication by University of Oxford researchers describes a new minimally invasive and inexpensive blood test that can identify cancer in patients with non-specific symptoms. A University of Oxford study published in Clinical Cancer Research , a journal of the American Association for Cancer Research, outlines a new type of blood test that can be used to detect a range of cancers and whether these cancers have spread (metastasised) in the body.

Health - Pharmacology - 04.01.2022
Superbug MRSA arose in hedgehogs long before clinical use of antibiotics
Superbug MRSA arose in hedgehogs long before clinical use of antibiotics
Scientists have found evidence that a type of the antibiotic resistant superbug MRSA arose in nature long before the use of antibiotics in humans and livestock, which has traditionally been blamed for its emergence.

Health - Pharmacology - 04.01.2022
Easy-to-take medicine better at suppressing HIV in children
Easy-to-take medicine better at suppressing HIV in children
A once-a-day antiretroviral medicine that is low-cost and easy for children to take is also more effective at suppressing HIV than standard treatments, according to a global trial led by researchers at UCL. The study, published today in The New England Journal of Medicine , found that dolutegravir-based regimens, which are already widely used to treat adults, reduced the chances of treatment failure among young people aged three to 18 by around 40% compared to standard treatments.

Health - Pharmacology - 03.01.2022
Scale of prevalence of a condition that can cause type 2 diabetes and high blood pressure
Share this page Share on Twitter Share on facebook Share on linkedin Share on email Scientists at the University of Birmingham are calling for changes to healthcare policy following research which has shown for the first time the scale of the impact of a condition associated with benign tumours that can lead to type 2 diabetes and high blood pressure.

Pharmacology - Health - 23.12.2021
Abiraterone could halve risk of prostate cancer death for some patients
Abiraterone could halve risk of prostate cancer death for some patients
Adding abiraterone to the standard treatment for locally advanced prostate cancer, where the cancer has a high chance of spreading, could halve the risk of death from the disease, according to the results of a UCL-led trial. The researchers suggest that hormone therapy using abiraterone with prednisolone, could significantly reduce prostate cancer deaths and improve outcomes for thousands of people every year.

Health - Pharmacology - 22.12.2021
Booster vaccination strongly enhances COVID-19 immunity in care home residents and staff - study
Booster vaccination strongly enhances COVID-19 immunity in care home residents and staff - study
Share this page Share on Twitter Share on facebook Share on linkedin Share on email A COVID-19 booster vaccination markedly increases immune response in residents and staff within care homes, making it vital that people living and working in these settings get their third 'jab', a new study reveals.

Health - Pharmacology - 22.12.2021
2021’s news highlights from the Faculty of Biology, Medicine and Health
Whether it's the continued impact of the Covid-19 pandemic or our world-leading science, our stories have been top news across the country and the world. Here's some of the most popular and interesting news releases from the Faculty of Biology, Medicine and Health in 2021.

Health - Pharmacology - 22.12.2021
Booster jabs strongly enhance Covid-19 immunity in care home residents and staff
Booster jabs strongly enhance Covid-19 immunity in care home residents and staff
A Covid-19 booster vaccination markedly increases immune response in residents and staff within care homes, according to a new preprint study co-led by UCL researchers, making it vital that people living and working in these settings get their third jab. Age and frailty are already recognised as major risk factors for severe Covid-19 outcomes, with elderly residents of long-term care facilities suffering much higher rates of mortality during the pandemic than the general population.

Health - Pharmacology - 21.12.2021
China-wide study will boost understanding of fatal surgical complication
China-wide study will boost understanding of fatal surgical complication
Share this page Share on Twitter Share on facebook Share on linkedin Share on email Older patients in hospitals across China took part in a major multi-centre open-label randomised clinical trial that showed there was no difference in post-operative delirium in older people with a hip fracture, if they had a general anaesthesia, or a regional anaesthesia.

Pharmacology - 21.12.2021
Four in ten consultations at GP clinics were with frequent attenders
A relatively small number of patients are accounting for a large proportion of GP workload, including face-to-face consultations, according to a UK study by University of Manchester experts. The study of over 160 million consultation events from 12.3 million patients, in 845 general practices between 2000 and 2019 showed four out of ten of the workload at GP clinics were with frequent attenders.

Health - Pharmacology - 20.12.2021
Covid-19 vaccine protection wanes after three months
Related Links Link to the study in the Lancet Covid-19 vaccine protection wanes after three months, study suggests The protection offered by the Oxford-Astra Zeneca Covid-19 vaccine declines after three months of receiving two doses, a study says. The findings - drawn from datasets in two countries - suggest that booster programmes are needed to help maintain protection from severe disease in those vaccinated with Oxford-Astra Zeneca, experts say.

Health - Pharmacology - 17.12.2021
Drug could more effectively treat patients hospitalised with COVID-19 pneumonia, early stage research finds
Share this page Share on Twitter Share on facebook Share on linkedin Share on email A proof-of-concept trial led by the University of Birmingham and University Hospitals Birmingham NHS Foundation Trust has identified a drug that may offer benefit some patients hospitalised with COVID-19 pneumonia.

Health - Pharmacology - 15.12.2021
New insights into impact of immune-suppressing treatments on COVID-19 vaccine effectiveness
Treatments used to help people with multiple sclerosis (MS) manage their condition can reduce the effectiveness of COVID-19 vaccines, according to a new study led by Cardiff University. Disease-modifying therapies (DMTs) are a group of treatments that suppress the body's immune system and are used by people with MS and other conditions such as cancer and rheumatoid disease.

Pharmacology - Health - 13.12.2021
New resistance-busting antibiotic combination could extend the use of ’last-resort’ antibiotics
Scientists have discovered a new potential treatment that has the ability to reverse antibiotic resistance in bacteria that cause conditions such as sepsis, pneumonia, and urinary tract infections. Carbapenems, such as meropenem, are a group of vital often 'last-resort' antibiotics used to treat serious, multi-drug resistant infections when other antibiotics, such as penicillin, have failed.

Health - Pharmacology - 10.12.2021
Prior SARS-CoV-2 infection increases strength and quality of immune response in double vaccinated care home staff and residents, reveals study
Share this page Share on Twitter Share on facebook Share on linkedin Share on whatsapp Share on email Elderly care home residents who have previously contracted and survived COVID-19 develop much stronger and higher antibody and cellular immune responses to two doses of vaccination than those without prior natural infection, finds new research led by the University of Birmingham.
1 2 3 4 5 ... 31 Next »